Dr. Adarsh K. Gupta has been named a 2026 Castle Connolly Top Doctor, marking his 15th consecutive year receiving this designation, which is awarded annually to only seven percent of the nation's licensed physicians based on peer nominations and rigorous review. A neuropsychiatrist with Sleep, TMS & Wellness Psychiatry, Dr. Gupta focuses on treatment-resistant depression, generalized anxiety disorder, obsessive-compulsive disorder, complex sleep-wake disorders, and neurobehavioral conditions unresponsive to traditional pharmacological interventions. His practice employs advanced procedures like Transcranial Magnetic Stimulation, ketamine-assisted treatment, functional near-infrared spectroscopy brain blood flow assessment, and quantitative electroencephalogram brain wave analysis to provide precision psychiatry and neuroscience-driven care.
Dr. Gupta stated that the recognition reflects his commitment to clinical excellence, innovation, and compassionate patient care, emphasizing his team's dedication to individualized psychiatric care prioritizing quality, trust, and long-term patient well-being. The practice features integrated diagnostic capabilities, including an on-site laboratory for brain wave analysis and cognitive testing, enabling precision diagnostics for comprehensive evaluation and personalized treatment plans. Dr. Gupta is actively involved in clinical research focused on optimizing treatment outcomes of TMS therapy in patients with major depressive and anxiety disorders using multimodal neurodiagnostic measures.
Dr. Gupta completed his psychiatry residency at New York University Medical Center and pursued fellowships in consultation-liaison psychiatry, brain imaging, and neuropsychiatry, holding academic roles such as attending consultation-liaison psychiatrist at Long Island Jewish Medical Center for 14 years. Castle Connolly publishes its Top Doctors list at https://castleconnolly.com and in various print and online partner publications, with a selection process involving peer nominations and review by a physician-led research team based on criteria like medical education, training, hospital appointments, and disciplinary histories, where doctors cannot pay to be selected.
The recognition highlights the evolving landscape of psychiatric care, where advanced neurodiagnostic tools and precision approaches are increasingly vital for treating complex mental health conditions. Dr. Gupta's repeated selection underscores the significance of integrating neuroscience with clinical psychiatry to address treatment-resistant cases and improve patient outcomes through personalized care strategies, demonstrating a shift toward more targeted and effective mental health interventions in modern medicine.
